Navigation Links
Kaden Commits to Address New Hampshire’s Opioid Epidemic
Date:11/14/2019

Kaden, the digital behavioral health company (formerly known as Thrivee), announced today its commitment to address the opioid addiction crisis in New Hampshire. The company is exploring a collaborative effort with Catholic Medical Center (CMC) to provide support and resources desperately needed by those struggling with opioid use disorder in the state.

Kaden is pleased to be a sponsor of CMC’s 5th Annual Summit: Management of the Opioid-Dependent Patient, taking place Friday, November 15, in Nashua, NH. This annual conference highlights the latest strategies and partnerships in the prevention, identification, and treatment of opioid-dependent patients, serving as an ideal venue to educate providers about Kaden’s groundbreaking virtual treatment services.

“We’re proud to be part of CMC’s efforts to provide individuals struggling with opioid addiction greater access to support and services,” said Dave Henderson, CEO of Kaden. “New Hampshire is the ideal setting to launch this platform, which will give patients real hope for recovery.”

Kaden’s Virtual Medication Assisted Treatment (vMAT) platform is a fully-integrated approach to treat those suffering from opioid use disorder, based on the gold standard of Medication Assisted Treatment. Leveraging virtual technology, the Kaden provider-practices in each state allow patients who have begun Medication Assisted Treatment at the hospital to access ongoing services and support via a smartphone, tablet or PC. The approach is convenient, intuitive and ultimately effective for long-term success relative to traditional treatment methods. Kaden’s platform integrates all aspects of the patient’s therapy and medical care and supports the patient with a concierge Patient Advocate available at any point along their treatment journey.

Kaden’s coordinated approach is centered, from the first in-person visit with a medical professional through all succeeding virtual visits and therapy, on the Kaden Technology Platform. This leading-edge intuitive interface allows the patient, therapist, medical prescriber, and the advocate all to communicate and collaborate in ways that ultimately help the patient to reclaim a healthy, productive lifestyle.

This release is for informational purposes only, and no offer regarding the solicitation of the purchase or sale of any security or securities product is made hereby.

For more information visit http://www.kadenhealth.com and http://www.catholicmedicalcenter.org.

About Kaden:
Based in New York City, Kaden is a behavioral health company dedicated to solving the greatest healthcare challenges of our time with ground-breaking technology and unwavering humanity. Kaden’s first product tackles the opioid addiction crisis by positively influencing human behavior and making advanced technologies and proven treatments accessible to all so that no one has to fight opioid or any addiction alone.

Company Contacts:
Kaden Sales and Business Development: Randy Ringpfiel -- randyr@kadenhealth.com
Kaden Marketing and Public Relations: Marc Warner -- marcw@kadenhealth.com

Read the full story at https://www.prweb.com/releases/kaden_commits_to_address_new_hampshires_opioid_epidemic/prweb16722088.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Dominick Vietri Joins Ancillare as New President; Commits to Building High-Performance Organization
2. Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
3. Foundation Venture Capital Group commits up to $500,000 in start-up advancing technology platform for tissue visualization
4. Henry Schein Commits $350,000 In Health Care Products To World Vision For Refugee Relief Efforts
5. IFRA Commits to Integrate Non Animal Data in Skin Sensitization Risk Assessment
6. CVS/pharmacy commits to Creating Safer Communities Through Multiple Prescription Drug Abuse Prevention Efforts
7. Lilly commits 780,000 additional vials of insulin to Life for a Child
8. Mezzion Pharma Commits To Phase 3 Clinical Trials Of Udenafil In Adolescents With A Single Functional Ventricle That Have Undergone Fontan Surgical Palliation
9. Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap
10. Cadence Health Foundation Commits $3.1 million To Support Services At Central DuPage Hospital and Delnor Hospital
11. American Capital Commits $391 Million in the Combination of Cambridge Major Laboratories and AAIPharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2019)... , ... December 09, 2019 ... ... innovator, has been honored for their work in improving workforce performance with ... Talent Management Technology category. The Excellence Awards recognize the best organizations that ...
(Date:12/8/2019)... ... December 08, 2019 , ... A new study from researchers at ... Appetite, finds teens overwhelmingly engage with fast food, unhealthy snacks, candy and soft drinks ... especially when teens get stuck inside with family members visiting from out of town. ...
(Date:12/6/2019)... Ariz. (PRWEB) , ... December 06, 2019 , ... ... Industry Nutrition Forum in Philadelphia to share information and ideas about working toward ... of the population. , “It’s vital that we develop a healthy and sustainable ...
Breaking Medicine Technology:
(Date:12/6/2019)... ... December 06, 2019 , ... NexLogic ... manufacturing implantable medical devices, which is a new and rapidly growing segment in ... medical devices are surgically inserted into various parts of the human body. They ...
(Date:12/6/2019)... ... ... for Tots to Give Free Toys to Children in Need , Dr. Alexis Parker, MD ... Lasair Aesthetic Health is spreading holiday cheer again this year by sponsoring the Toys for ... more than 25-dollars, will get FIVE units of Botox (a $60 value) for free from ...
(Date:12/6/2019)... ... December 06, 2019 , ... Dr. Scott Howell, a 2019 graduate of Trident ... the health benefits of coconut oil in the 7 November 2019 edition of ... Cardiometabolic Profile: A Structured Literature Review,” led by Dr. Hector O. Santos, examines the ...
(Date:12/5/2019)... (PRWEB) , ... December 05, 2019 , ... ... education planning, has announced the Top 54 RHIT Degree Programs for 2020. The ... universities in the nation. Each program is evaluated based on curriculum quality, graduation ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... Mesocarp Extract®, provides protection from disruptions to cells and tissue and inflammation that ... of Jet Lag, is available in a dietary supplement product called Prepair™ ...
Breaking Medicine News(10 mins):